At Takeda R&D’s Center for External Innovation (CEI), our unique model supports diverse and flexible partnerships around the world to harness innovation across the discovery and development lifecycle.
The breadth and depth of experience across our CEI teams, paired with that of our R&D leaders, ensures we can seek out the best potential partners to propel Takeda’s R&D Strategy forward.
We execute mutually beneficial strategic collaborations to build our R&D pipeline and capabilities.
We invest in and create innovative companies aligned with our R&D focus, delivering strategic growth opportunities for Takeda.
In combination with our internal research capabilities at Takeda R&D, we establish partnerships to accelerate innovation. We actively engage with innovative ecosystems around the world to translate science into highly transformative medicines within our R&D focus areas:
Oncology, Rare Genetics & Hematology, Neuroscience and Gastroenterology.